What is the Triglyceride-Glucose (TyG) Index?
The Triglyceride-Glucose (TyG) index is a validated clinical metric used to evaluate insulin sensitivity and diagnose insulin resistance (IR). First proposed by Simental-Mendía et al., the index combines two standard, inexpensive biomarkers found on a routine annual lipid panel and metabolic screening: fasting serum triglycerides and fasting plasma glucose.
Historically, measuring insulin resistance required either the complex, research-only hyperinsulinemic-euglycemic clamp or the HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). However, HOMA-IR requires a direct fasting insulin assay—a test that is expensive, rarely ordered during standard checkups, and plagued by significant variability between diagnostic laboratories. The TyG index provides an accessible, standardized alternative that performs with comparable or even superior sensitivity.
*Note: "ln" represents the natural logarithm (base e). If your laboratory values are measured in mmol/L, they must be converted to mg/dL before applying the natural log formula (Triglycerides: 1 mmol/L = 88.57 mg/dL; Glucose: 1 mmol/L = 18.018 mg/dL). Our calculator performs this conversion automatically.
TyG Index Reference Ranges & Clinical Interpretation
Extensive epidemiological research spanning diverse cohorts worldwide has established clear diagnostic thresholds for the TyG index:
| TyG Score | Status | Insulin Sensitivity | Cardiometabolic Risk |
|---|---|---|---|
| < 8.5 | Normal | Optimal Insulin Sensitivity | Low baseline risk |
| 8.5 – 8.8 | Borderline / Mild IR | Declining Sensitivity | Moderate / Early metabolic dysfunction |
| > 8.8 | Elevated | Significant Insulin Resistance | High risk for T2D, MASLD, and Atherosclerosis |
Why Is the TyG Index Important? Clinical Utility
Insulin resistance is the unifying pathophysiological defect behind the modern metabolic epidemic. By calculating your TyG index, clinicians and individuals can detect asymptomatic metabolic dysfunction years before overt Type 2 Diabetes is clinically diagnosed.
1. Non-Alcoholic Fatty Liver Disease (MASLD / NAFLD)
The liver plays a central role in triglyceride synthesis. Elevated hepatic de novo lipogenesis directly causes higher circulating fasting triglycerides. Multiple large-scale cohort studies demonstrate that individuals with a TyG index greater than 8.8 have an exponentially increased risk of developing steatotic liver disease and hepatic fibrosis.
2. Atherosclerosis & Cardiovascular Disease (CVD)
Elevated TyG values are closely correlated with arterial stiffness, coronary artery calcification (CAC), and microvascular endothelial damage. Research published in the Journal of the American Heart Association (JAHA) highlights the TyG index as an independent predictor of myocardial infarction and ischemic stroke, even among non-diabetic populations.
3. Prediction of Type 2 Diabetes Mellitus
Fasting blood sugar alone often stays within "normal" limits (< 100 mg/dL) for over a decade while pancreatic beta cells hypersecrete insulin to compensate. Because the TyG index incorporates triglycerides—which rise rapidly during early insulin resistance—it catches metabolic deterioration long before standard glucose tests flag a problem.
TyG Index vs. HOMA-IR: An Evidence-Based Comparison
| Feature | TyG Index | HOMA-IR |
|---|---|---|
| Required Biomarkers | Fasting Glucose + Triglycerides | Fasting Glucose + Fasting Insulin |
| Cost & Accessibility | Very Low (Standard lipid panel) | Moderate to High (Specialized test) |
| Standardization | Universal across all global labs | Poor (High inter-assay variation) |
| Prediction of Fatty Liver | Superior in multiple prospective trials | Moderate |
Evidence-Based Strategies to Lower Your TyG Index
Because the TyG index is governed entirely by glucose and triglyceride metabolism, lifestyle interventions yield rapid, measurable improvements within 8 to 12 weeks:
- Eliminate Refined Carbohydrates & Liquid Fructose: Added sugars and ultra-processed starches stimulate hepatic lipogenesis, dramatically elevating circulating triglycerides.
- Adopt Time-Restricted Eating or Low-Carb Nutrition: Reducing carbohydrate load and extending fasting windows lowers baseline insulin secretion and depletes excess hepatic glycogen and lipid stores.
- Zone 2 Cardiovascular Training & Resistance Exercise: Skeletal muscle is responsible for roughly 80% of postprandial glucose disposal. Muscle contraction activates GLUT4 translocation independently of insulin.
- Target Visceral Adiposity: Visceral fat directly drains into the portal vein, worsening hepatic insulin resistance. A modest 5–10% weight loss can normalize both glucose and lipid profiles.
- Consider Omega-3 Fatty Acids: High-purity EPA/DHA supplementation (2–4g daily under clinical guidance) is known to lower plasma triglycerides by 20–30%.